Abstract
Objective Recalled childhood adiposity is inversely associated with breast cancer observationally, including in Mendelian randomization (MR) studies, questioning its role. Breast cancer studies recruited in adulthood only include survivors of childhood adiposity and breast cancer. We assessed recalled childhood adiposity on participant reported sibling and maternal breast cancer to ensure ascertainment of non-survivors using MR.
Study Design and Setting We obtained independent strong genetic predictors of recalled childhood adiposity for women and their associations with participant reported own, sibling and maternal breast cancer from UK Biobank genome wide association studies (GWAS). We obtained MR inverse variance weighting estimates.
Results Childhood adiposity in women was inversely associated with own breast cancer (odds ratio (OR) 0.66, 95% confidence interval (CI) 0.52 to 0.84) but unrelated to participant reported sibling (OR 0.85, 95% CI 0.60 to 1.20) or maternal breast cancer (OR 0.84, 95% CI 0.67 to 1.05 respectively).
Conclusion Weaker inverse associations of recalled childhood adiposity with breast cancer with more comprehensive ascertainment of cases before recruitment suggests the inverse association of recalled childhood adiposity with breast cancer is due to selection bias arising from preferential selection of survivors. Greater consideration of left truncation in public health relevant causal inferences is warranted.
Highlights Recalled childhood adiposity is inversely associated with breast cancer.
Studies of childhood exposures recruited in adulthood are open to left truncation.
Participant reports about family members include deaths before recruitment.
We tested childhood adiposity on sibling breast cancer using Mendelian randomization.
Childhood adiposity with sibling breast cancer was null, suggesting left truncation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
